Things started off looking strong for the Team TGM lineup at Daytona. The #46 qualified P4, and the #64 rolled off from P33. From the outset, both cars showed they were ready to compete.

Everyone agrees the healthcare system needs to change. But almost no one agrees on how to change it. And even when they do? It takes forever.

Every new year starts with noise. Resolutions. Predictions. Overwhelm disguised as motivation. But if there’s one thing I’ve learned in leadership, whether in the boardroom, on the track, or at the Foundation, it’s that starting strong doesn’t mean doing everything. It means doing the right things, on purpose.

Most people think of philanthropy as charity. I think of it as an investment, with an expected return measured in discoveries, not dollars. At the JKTG Foundation, we don’t fund cancer research the traditional way. We don’t issue massive RFPs or wait for consensus to form. We move quickly, prioritize bold thinkers, and stay close to the science. Why? Because the diseases we’re up against, like breast cancer, won’t wait.

Racing looks like adrenaline. But it runs on calculation. You’re balancing tire wear, fuel strategy, competitor behavior, weather shifts, traffic, and more, all in real time. And you can’t afford to guess. One bad call costs you the race. One smart call can flip the entire outcome.

Transparency sounds like a good thing. And in many cases, it is. But in healthcare policy, I’ve seen a troubling pattern: Transparency gets weaponized. Not to inform decisions. Not to improve outcomes. But to delay progress, justify inaction, or create political cover.

There’s a myth in leadership that experience automatically makes you better. But I’ve learned, on the racetrack, in health policy, and in research funding, that experience without adaptability is just a heavier anchor. The world changes. Fast. And if you’re clinging to “what used to work,” you’re not leading. You’re coasting.

That’s what happened with a recent study the JKTG Foundation supported, one that explored how iron-based nanoparticles could help detect and treat tumors more safely. This wasn’t hype. It was smart, specific science. And it’s the kind of work we’re proud to back.

You don’t usually associate spreadsheets with survival rates. But that’s exactly the connection Dr. Paul Macklin is exploring in our latest Driving Research episode.

For decades, we’ve known Medicare’s financial challenges were coming. The math hasn’t changed. The program continues to spend more than it brings in, and the demographic reality is unavoidable: more retirees, fewer workers, and escalating healthcare costs.

There’s a common trap leaders fall into: They assume because they’ve seen something before, they know exactly how to handle it now. I’ve seen this play out in racing. I’ve seen it in healthcare policy meetings. I’ve seen it in boardrooms. And I’ve learned that past experience can mislead you if you treat it like gospel.

You get results: faster, sharper, and more aligned with what patients truly need. That was the driving force behind the 9th annual JKTG Symposium, held October 15, 2025 in Washington D.C. This year’s theme, "Improving Breast Cancer Outcomes: Revealing and Targeting Tumor–Immune Interactions," was more than a title. It was a call to action.

This weekend marked the final race of our season: Road Atlanta. And I’ll be honest… We knew all we had to do was start the race to win the Bronze Cup Championship. But that’s never been how we operate. We came to compete.

If you want to slow progress down, wrap it in red tape. That’s the reality for far too much medical research in this country. Scientists with bold ideas spend more time formatting grant proposals than actually running experiments. And when the funding does come through, it’s often a year too late, tied up in approval cycles, institutional requirements, and layers of administrative overhead. The worst part? Some of the most promising ideas never even get submitted. They’re too

Everyone seems to be chasing work-life balance. It’s become one of those phrases people throw around in performance reviews, wellness programs, and leadership retreats. The idea sounds great: work hard, but not too hard. Make time for family, fitness, and fun. Keep everything “in check.” But here’s the problem:

The IMSA Michelin Pilot Challenge rolled into Indianapolis Motor Speedway this past weekend for the 2025 Battle on the Bricks, and Team TGM showed up ready to compete!

When most people think about the cost of healthcare, they look at billing, drug prices, or insurance premiums. What they don’t see is the hidden cost that providers shoulder to comply with the rules. Every regulation comes with a price, not just in dollars, but also in terms of time, infrastructure, staffing, and attention. And when policymakers underestimate that cost, it distorts everything from reimbursement to patient access...

Every field has its trends, and science is no exception. One year, it’s immunotherapy. Next, it’s AI in diagnostics. Big breakthroughs and high-impact journals are great. But when funding begins to chase popularity instead of substance, something gets lost. The cost of chasing what’s popular in science is high. It’s paid by researchers working on foundational problems who can’t get funded. It’s paid by patients waiting for treatments that don’t check the right boxes. And it’s

In racing, not every weekend brings drama. But sometimes, that’s exactly what you want. At Virginia International Raceway (VIR), both Team TGM cars showed up ready. No chaos, no carnage; just smart strategy, focused execution, and steady results that paid off in the long game.

Leadership doesn’t always come with the most years on your resume. In fact, some of the strongest leaders I’ve seen were not the most experienced person in the room. They didn’t know everything. But they knew how to carry themselves, how to make decisions, and how to guide the group without pretending to have all the answers. That’s what confidence in leadership actually looks like. It’s not loud. It’s not about titles or dominance. It’s about presence...